Apollo medical holdings, inc. announces purchase of controlling interests in sun clinical laboratories

Alhambra, calif., june 2, 2021 /prnewswire/ -- apollo medical holdings, inc. ("apollomed," and together with its subsidiaries and affiliated entities, the "company") (nasdaq: ameh), a leading physician-centric, technology-powered healthcare company focused on value-based care, today announced that the company has entered into a definitive agreement with sun clinical laboratories ("sun labs"), under which apollomed will purchase controlling interests in sun labs for $4.0 million.
AMEH Ratings Summary
AMEH Quant Ranking